Insider · CIK 0001684077
Erin N Kane
Files at CC (Chemours Co), ASIX (AdvanSix Inc.). First filing Nov 4, 2024, latest Feb 4, 2025.
In brief
Erin N Kane files SEC Form 4 as CEO and director at ASIX (AdvanSix Inc.), and also at CC (Chemours Co). Since Nov 4, 2024, Erin N Kane has reported 0 open-market buys worth $0 and 4 open-market sells worth $605k, the latest filed on Feb 4, 2025.
A track record needs three past buys with six months of prices behind them; Erin N Kane has 0, so none is measured yet.
The newest scored trade: sold $151k of ASIX on Feb 3, 2025, filed Feb 4, 2025, scored 16 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ASIX: AdvanSix Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | AdvanSix Inc. | $151k 5,000 shares | -1% | +15% from low-7% from high | |
| 16Weak | AdvanSix Inc. | $141k 5,000 shares | -1% | +4% from low-16% from high | |
| 24Weak | AdvanSix Inc. | $161k 5,000 shares | -1% | - | |
| 31Weak | AdvanSix Inc. | $152k 5,000 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 3, 2025 | ASIX AdvanSix Inc. | 5,000 0.02% of outstanding | $151k | Feb 3, 2025 | $302k |
| Jan 2, 2025 | ASIX AdvanSix Inc. | 5,000 0.02% of outstanding | $141k | Jan 2, 2025 | $313k |
| Dec 2, 2024 | ASIX AdvanSix Inc. | 5,000 0.02% of outstanding | $161k | Dec 2, 2024 | $445k |
| Nov 1, 2024 | ASIX AdvanSix Inc. | 5,000 0.02% of outstanding | $152k | Nov 1, 2024 | $293k |
| Mar 28, 2024 | ASIX AdvanSix Inc. | 5,000 0.02% of outstanding | $141k | Mar 28, 2024 | none |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | CC Chemours Co | AGrant or award Common Stock | +7,182 | $0.00 | $0 | 74,063 | May 8, 2026 |
| Feb 28, 2026 | ASIX AdvanSix Inc. | FTax withholding Common Stock, par value $0.01 | -33,642 | $17.47 | $588k | 623,103 | Mar 3, 2026 |
| Feb 26, 2026 | ASIX AdvanSix Inc. | AGrant or award Common Stock, par value $0.01 | +111,298 | $17.79 | $2.0M | 656,745 | Mar 2, 2026 |
| Apr 22, 2025 | CC Chemours Co | AGrant or award Common Stock | +14,096 | $0.00 | $0 | 65,194 | Apr 24, 2025 |
| Feb 28, 2025 | ASIX AdvanSix Inc. | FTax withholding Common Stock, par value $0.01 | -22,213 | $27.75 | $616k | 480,582 | Mar 4, 2025 |
| Feb 28, 2025 | ASIX AdvanSix Inc. | AGrant or award Common Stock, par value $0.01 | +64,865 | $0.00 | $0 | 545,447 | Mar 4, 2025 |
| Feb 3, 2025 | ASIX AdvanSix Inc. | SOpen-market sale Common Stock, par value $0.0110b5-1 | -4,400 | $30.12 | $133k | 503,395 | Feb 4, 2025 |
| Feb 3, 2025 | ASIX AdvanSix Inc. | SOpen-market sale Common Stock, par value $0.0110b5-1 | -600 | $30.71 | $18k | 502,795 | Feb 4, 2025 |
| Jan 2, 2025 | ASIX AdvanSix Inc. | SOpen-market sale Common Stock, par value $0.0110b5-1 | -4,700 | $28.10 | $132k | 508,095 | Jan 3, 2025 |
| Jan 2, 2025 | ASIX AdvanSix Inc. | SOpen-market sale Common Stock, par value $0.0110b5-1 | -300 | $28.90 | $8,670 | 507,795 | Jan 3, 2025 |
| Dec 2, 2024 | ASIX AdvanSix Inc. | SOpen-market sale Common Stock, par value $0.0110b5-1 | -5,000 | $32.29 | $161k | 512,795 | Dec 4, 2024 |
| Nov 1, 2024 | ASIX AdvanSix Inc. | SOpen-market sale Common Stock, par value $0.0110b5-1 | -3,500 | $30.15 | $106k | 519,295 | Nov 4, 2024 |
| Nov 1, 2024 | ASIX AdvanSix Inc. | SOpen-market sale Common Stock, par value $0.0110b5-1 | -1,500 | $30.87 | $46k | 517,795 | Nov 4, 2024 |
| Feb 28, 2024 | ASIX AdvanSix Inc. | AGrant or award Common Stock, par value $0.01 | +106,213 | $0.00 | $0 | 553,121 | Mar 1, 2024 |
| Feb 28, 2024 | ASIX AdvanSix Inc. | FTax withholding Common Stock, par value $0.01 | -54,328 | $27.36 | $1.5M | 498,793 | Mar 1, 2024 |
| Feb 28, 2024 | ASIX AdvanSix Inc. | AGrant or award Common Stock, par value $0.01 | +63,962 | $0.00 | $0 | 562,755 | Mar 1, 2024 |
| Feb 24, 2024 | ASIX AdvanSix Inc. | FTax withholding Common Stock, par value $0.01 | -13,596 | $27.81 | $378k | 446,908 | Feb 27, 2024 |
Questions about Erin N Kane
Answered from the filings on this page, as of the latest one.
Is Erin N Kane buying or selling?
Not in the last 12 months. Erin N Kane's latest open-market trade on SEC Form 4 was sold $151k of ASIX on Feb 3, 2025.
How did Erin N Kane's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Erin N Kane has 0.
Where does Erin N Kane file Form 4?
Erin N Kane has filed Form 4 at ASIX (AdvanSix Inc.) as Chief Executive Officer; CC (Chemours Co). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.